| Spectranetics Corporation |
|
|
96 Talamine Court
Colorado Springs, CO 80907-5186 USA
phone:
(719) 633-8333
fax:
1-719-633-8791 |
| Symbol |
SPNC |
| Exchange |
Nasdaq |
| Founded |
1984 |
| Employees |
142 |
|
|
 www.spectranetics.com |
|
| Research Sector |
Medical Devices & Tech |
|
|
| Summary Description |
| Devices for minimally invasive cardiovascular system surgeries. |
|
| Management |
| John G. Schulte, President and Chief Executive Officer; Jonathan W. McGuire, Chief Operating Officer; Guy A. Childs, Vice President, Chief Financial Officer; Adrian E. Elfe, Vice President, Quality Assurance and Regulatory Affairs; Lawrence E. Martel, Jr., Vice President, Operations; Kelly W. Elliott, Vice President, Clinical Affairs and Regulatory Submissions; Stephen D. Okland, Jr., Vice President, Sales and Marketing |
|
|
|
|
| Keywords |
| cardiovascular, occlusions, Cardiology, cardiac, heart, coronary, heart, laser, excimer laser, catheter, sheath, minimally invasive, atherectomy, clogged arteries, obstructed arteries |
|
|
|
|
Description |
| Spectranetics develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system, in conjunction with its proprietary excimer laser system. |
|
| Products / Services |
Spectranetics' excimer laser system includes the CVX-300 laser unit and various fiber-optic delivery devices, including disposable catheters and sheaths. The excimer laser system is used in complex atherectomy procedures to open clogged or obstructed arteries in the coronary vascular system. It is also used to remove lead wires from patients with implanted pacemakers or cardioverter defibrillators, which are electronic devices that regulate the heartbeat.
|
|
| Technology / Differentiation |
| Excimer laser technology delivers comparatively cool ultraviolet light in short, controlled energy pulses to ablate or remove blockages. |
|
| Market / Customers |
Coronary Artery Disease occurs when coronary arteries become narrowed or blocked by a buildup of plaque (cholesterol or other materials). When the blockage is severe, the flow of blood and oxygen to your heart muscle is reduced.
|
|
| Competitors / Substitutes / Alternatives |
Boston Scientific Corp., Medtronic, Inc., Pfizer, Inc.
|
|
| Status |
| Spectranetics' excimer laser system is approved in both the United States and Europe for use in multiple, minimally invasive cardiovascular applications. In 2004, Spectranetics received 510(k) clearance from the FDA for its CliRpath laser catheters, which are indicated for use in the endovascular treatment of peripheral artery disease where total obstructions are not crossable with a guidewire. |
|
|
|
| |
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
